Regeneron Pharmaceuticals | REGN - Trade Debtors

Stock Price
744.44
Daily Change
-7.13 -0.95%
Monthly
-0.65%
Yearly
21.87%
Q2 Forecast
735.49

Regeneron Pharmaceuticals reported $5.74B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Agenus USD 22.44M 1.14M Dec/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
Astellas Pharma JPY 810.23B 75.43B Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
J&J USD 21.33B 3.72B Dec/2025
Kyowa Hakko Kirin JPY 181.2B 29.38B Dec/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 397M 186.13M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025